electrokinetics for sample preparation of biological molecules in biological samples using...

14
Electrokinetics for Sample Preparation of biological molecules in Microfluidic Systems Aliaa I. Shallan, 1,2 , Rosanne M. Guijt 2 , Michael C. Breadmore 1 1 Australian Centre for Research on Separation Science, School of Chemistry, University of Tasmania, Private Bag 75, Hobart, Tasmania 7001, Australia 2 Australian Centre for Research on Separation Science, School of Pharmacy, University of Tasmania, Private Bag 26, Hobart, Tasmania 7001, Australia. Abstract Sample preparation is the first part of every analytical method, but is often considered only after optimization of the method. It is traditionally performed using a range of highly manual techniques, with solid-phase extraction, liquid-liquid extraction, protein precipitation, ultracentrfiguation, etc, being used depending on the targets and the application. Here, we will focus on alternatives based on electrokinetics for applications including sample clean up, concentration and derivatisation of large biological molecules (DNA, peptides, and proteins) of diagnostic importance, as well as small molecules as a tool for therapeutic drug monitoring. The review describes these approaches in terms of mechanism, applicability and potential to be integrated into a lab on a chip device for directly processing biological samples. Introduction The challenge for personalized medicine and point-of-care devices is to be able to provide a laboratory-based measurement within minutes using exceptionally small and highly integrated instrumentation that can be used by an unskilled and minimally trained operator. The targets are diverse, ranging from small molecule drugs and their metabolites, through to large macromolecules such as proteins and DNA, each of which present different analytical challenges that need to be overcome. Common to all is the need to deal directly with crude, unprocessed biological samples, and the need to integrate a simple and effective strategy to manipulate the sample into a form such that the target can be measured. There is no one strategy that is universally applicable and a unique approach is required for each application and depends upon the sample type, target molecule, timeframe, cost and detection limit. Genetic targets such as mutations in BRCA1 and BRAC2, which indicate a higher susceptibility of breast cancer, require that the DNA be isolated and purified, the relevant regions amplified through PCR and the fragments detected to confirm the presence of the gene. The nature of PCR is highly beneficial for providing both selectivity and sensitivity. But PCR is only applicable for DNA/RNA. For other biomarkers, such as the prostate-specific antigen (PSA), 1 a biomarker for prostate cancer, and proteins like cardiac troponin I, a marker for cardiac myocyte injury, 2 a different approach is required. The challenge in detecting protein biomarkers is that the upper reference limit is 0.1 ng/ml, which is 10 8 times less than the high abundant plasma proteins such as albumin and IgG (> mg/ml). Despite this concentration difference, it is possible to use an Immunoaffinity assays to measure these biomarkers. An antibody achieves selectivity and facilitates detection of the coloured, fluorescent, or radiolabeled conjugate. Alternative, the activity of an enzyme, bound to a secondary detection antibody, can be used to achieve the necessary sensitivity. Various immunoassays have been implemented in microfluidic devices with varying degrees of success. 3, 4 Immunoassays, however, require a selective and specific antibody, and for small molecules targets, such as drugs and their metabolites, an antibody, or more recently, an aptamer, are not available with the necessary selectivity at an affordable cost. Small molecules in clinical samples are often analysed by liquid chromatography (LC), with in most instances requiring at least 6 manual steps (collect blood, centrifuge, add reagent, centrifuge, decant supernatant and inject into LC system), although it is possible to automate some of these processes through solid-phase extraction or robotic handling systems. Nevertheless, integration of these in a microfluidic device is not trivial.

Upload: independent

Post on 20-Nov-2023

0 views

Category:

Documents


0 download

TRANSCRIPT

Electrokinetics for Sample Preparation of biological molecules in

Microfluidic Systems

Aliaa I. Shallan, 1,2, Rosanne M. Guijt2, Michael C. Breadmore1 1Australian Centre for Research on Separation Science, School of Chemistry, University of Tasmania,

Private Bag 75, Hobart, Tasmania 7001, Australia

2Australian Centre for Research on Separation Science, School of Pharmacy, University of Tasmania,

Private Bag 26, Hobart, Tasmania 7001, Australia.

Abstract

Sample preparation is the first part of every analytical method, but is often considered only after

optimization of the method. It is traditionally performed using a range of highly manual techniques,

with solid-phase extraction, liquid-liquid extraction, protein precipitation, ultracentrfiguation, etc,

being used depending on the targets and the application. Here, we will focus on alternatives based on

electrokinetics for applications including sample clean up, concentration and derivatisation of large

biological molecules (DNA, peptides, and proteins) of diagnostic importance, as well as small

molecules as a tool for therapeutic drug monitoring. The review describes these approaches in terms of

mechanism, applicability and potential to be integrated into a lab on a chip device for directly

processing biological samples.

Introduction

The challenge for personalized medicine and point-of-care devices is to be able to provide a

laboratory-based measurement within minutes using exceptionally small and highly integrated

instrumentation that can be used by an unskilled and minimally trained operator. The targets are

diverse, ranging from small molecule drugs and their metabolites, through to large macromolecules

such as proteins and DNA, each of which present different analytical challenges that need to be

overcome. Common to all is the need to deal directly with crude, unprocessed biological samples, and

the need to integrate a simple and effective strategy to manipulate the sample into a form such that the

target can be measured.

There is no one strategy that is universally applicable and a unique approach is required for

each application and depends upon the sample type, target molecule, timeframe, cost and detection

limit. Genetic targets such as mutations in BRCA1 and BRAC2, which indicate a higher susceptibility

of breast cancer, require that the DNA be isolated and purified, the relevant regions amplified through

PCR and the fragments detected to confirm the presence of the gene. The nature of PCR is highly

beneficial for providing both selectivity and sensitivity. But PCR is only applicable for DNA/RNA.

For other biomarkers, such as the prostate-specific antigen (PSA),1 a biomarker for prostate cancer,

and proteins like cardiac troponin I, a marker for cardiac myocyte injury,2 a different approach is

required. The challenge in detecting protein biomarkers is that the upper reference limit is 0.1 ng/ml,

which is 108 times less than the high abundant plasma proteins such as albumin and IgG (> mg/ml).

Despite this concentration difference, it is possible to use an Immunoaffinity assays to measure these

biomarkers. An antibody achieves selectivity and facilitates detection of the coloured, fluorescent, or

radiolabeled conjugate. Alternative, the activity of an enzyme, bound to a secondary detection

antibody, can be used to achieve the necessary sensitivity. Various immunoassays have been

implemented in microfluidic devices with varying degrees of success.3, 4 Immunoassays, however,

require a selective and specific antibody, and for small molecules targets, such as drugs and their

metabolites, an antibody, or more recently, an aptamer, are not available with the necessary selectivity

at an affordable cost. Small molecules in clinical samples are often analysed by liquid chromatography

(LC), with in most instances requiring at least 6 manual steps (collect blood, centrifuge, add reagent,

centrifuge, decant supernatant and inject into LC system), although it is possible to automate some of

these processes through solid-phase extraction or robotic handling systems. Nevertheless, integration

of these in a microfluidic device is not trivial.

While it is possible to simply integrate existing laboratory strategies seamlessly in a

completely integrated microfluidic device, the question must be asked whether this is the right

approach and whether there are alternative ways to deal with crude samples in that by their very nature

are amenable to miniaturization. Electrokinetics is the perfect approach to realise this. It involves the

manipulation of fluid and ion movement with electric fields and was the first separation method chosen

for implementation in microfluidic devices in the early 90’s because only a high voltage power supply

is required to transport and separate analytes, avoiding the need to use pumps. The last two decades

have seen the development of a number of simple and powerful electrokinetic approaches for sample

treatment, particularly for target concentration to enhance sensitivity. A number of these have been

implemented in a microfluidic device to great effect. For example, the million fold enhancement

factors achieved by isotachophoresis5 or enrichment at nano-/micro-channel interfaces.6, 7 The

limitation however is that the majority of these are not applicable to a crude sample and require some

other form of sample preparation. In some instances there is potential for this to be performed in an

integrated chip, such as extractions through droplets8 or laminar in a H-filters9, however, these have yet

to be coupled with a microfluidic separation. It is worth noting that the greater the complexity of the

processes that need to occur in the microfluidic device, the more complex the instrumentation required

to operate it and the less likely it is to be robust and reliable.

This review will focus specifically on electrokinetics in microchips for sample treatment of a

crude unprocessed sample – the first step in the analytical chain – because this is the most challenging

part of the process from a point-of-care perspective. The approaches discussed need not be specific to

point-of-care device – in some instances they are attractive for implementation in laboratory based

instrumentation to service more routine analyses – but this is the hardest application environment and

is the area where electrokinetics has significant advantages over current alternative approaches.

Electrokinetics – the basics.

The premise of electrokinetic sample preparation is to isolate and perhaps concentrate the

target molecule(s) through the application of electric fields. Within this context, it is important to

understand that two fundamental processes will occur. The first, electrophoresis, is the movement of

ions to the electrode of opposite charge with a speed defined by the charge and size of the ion. The

second is electroosmosis – the movement of counter ions at a surface which gives rise to physical

movement of the liquid, called electroosmotic flow (EOF). The magnitude and direction of the flow

depend on the surface charge and composition of the liquid. As will be seen from many of the

discussions below, understanding and control of electrophoresis and EOF along with other variables

can be used to great effect to manipulate a sample. At its simplest, it is simply used to transport

analytes and allow them to be “injected” for analysis – this is the basis of the commercial microfluidic

device developed for therapeutic drug monitoring of lithium.10 Lithium is prescribed for patients

suffering from bipolar depression and close monitoring of blood levels is necessary to ensure effective

treatment and avoid toxicity. The device incorporates a cellulose ester membrane to remove blood cells

and allow movement of cations through to a water plug where they are concentrated prior to separation.

Conductivity detection was used to measure lithium concentrations which were normalized to blood

sodium levels for quantitation. This instrument is one of the most sophisticated point-of-care devices

currently around, but is still very limited in its abilities and it cannot be easily extended to other

therapeutic agents that are at considerably lower therapeutic levels than Lithium.

The most widespread use of electrokinetics for sample preparation is for stacking – the

concentration of the target species at the sample/electrolyte interface. Stacking is particularly effective

when the conductivity of the injected sample is at least 10 times lower than that of the separation

electrolyte – called field amplified sample stacking (FASS). If ions are injected under field amplified

conditions (called field amplified sample injection, FASI) then even greater concentration factors can

be obtained. This can be explained by the fact that ions are injected at a rate according to the sum of

their electrophoretic mobility and the EOF while the amount of solvent injected is determined only by

the EOF. Thus when the same physical volume of sample is injected, more analyte ions can be injected

when compared to a hydrodynamic injection with the same matrix volume and thus the sensitivity can

be improved. Gong et al. used this phenomenon to design a microchip to concentrate three fluorescent

dyes by up to 160-fold over standard pinched injection.11 While powerful, field amplified sample

injection (FASI) is reliant on a low ionic strength sample and is therefore not directly applicable to the

relative high salt content of biological samples.

A simple and elegant way to deal with high salt samples is pH-mediated sample stacking,

introduced by Lunte and co-workers.12 This overcomes the problem of high conductivity matrix by

neutralizing the weak counter ions in the sample by strong acids or bases injected electrokinetically

after the sample. The weak acid/base is neutralized creating a low conductivity zone. Following

careful optimization of the injection times for the acid/base, the detection limits of PCR amplified

DNA in microchip gel electrophoresis were decreased by a factor 8 by neutralizing the Tris ions from

the run buffer by electrokinetically injected hydroxide ions and forming a low conductivity zone.13

Shiddiky and Shim14 reached 25,000-fold increase in sensitivity within 125 s using microchip

electrophoresis of DNA with electrochemical detection. They combined FASI with gold nanoparticle

modified buffers and electrodes. The modified electrodes resulted in 10 times peak current compared to

bare electrodes and a 450-fold enhancement due to the stacking step alone. We suspect that the low

ionic strength of the sample, 10 mM Tris-HCl at pH 8.0, contributed to the high concentration factor

achieved, making this approach not directly applicable to biological samples.

Electrophoretic separations for sample pretreatment

One of the main purposes of sample pretreatment is to isolate and concentrate the target

species. This is typically performed with low resolution techniques – all compounds of interest are

isolated and then introduced collectively for analysis. A high-resolution separation can be equally as

powerful for sample pretreatment, and is in fact one of the most powerful methods for altering a sample

composition prior to a second analytical separation. This is the basis of 2D electrophoresis in which

proteins are first separated by isoelectric focusing (IEF) before a second separation by SDS

polyacrylamide gel electrophoresis (SDS-PAGE). Separation in miniaturized IEF is more efficient as

higher electric fields can be applied while Joule heating is kept to minimum as a result of the larger

surface area to volume. IEF was coupled with CZE for the separation of standard proteins.15 The IEF

step formed separated zones in less than 1 min and offered 73-fold concentration enhancement. The

system achieved a total peak capacity of ~ 1300. Microchip SDS-PAGE/IEF separation of a

fluorescently labeled protein standard containing proteins with a Mwt range of 20 000–200 000 Da was

achieved in less than 30 s using the high sieving power of a photopatterned polyacrylamide gel in ultra

short channels.16

Isotachophoresis (ITP) is one of the oldest electrokinetic techniques, and unlike IEF which is

only applicable to analytes with a pI, ITP is applicable to all charged species. It is based on placing the

target ions between a high mobility co-ion in the leading electrolyte (LE) at the front and a low

mobility co-ion in the terminating electrolyte (TE) at the back. When the voltage is applied, ions within

the sample adjust their velocity to satisfy the mass and charge balance through the capillary according

to Kohlrausch regulating function. The result is self-sharpening zones in descending mobility at a

speed dictated by the LE co-ion mobility and a zone length determined by the concentration of the

analyte. The length of each zone is also dependent on the physical geometry of the microchannel. The

use of non-uniform microchannels in which the cross-section area becomes smaller causes the zones to

become longer to conserve mass and charge according to the Kohlrausch regulating function. This was

demonstrated for indirect fluorescence detection of BisTris as a model analyte17. Subsequently an

enhancement of 10,000-fold for fluorescent proteins were achieved through a 100 times reduction in

channel dimensions18 which was then applied for the determination of the biomarker cardiac troponin I 19 and its phosphorylated forms20 in the presence of serum proteins and direct fluorescence detection

with a similar concentration factor.

One of the unique aspects of ITP is that ions are equalized to a concentration defined by their

mobility and the leading ion concentration. Ions with an initial concentration higher than the leader are

diluted, while ions with a concentration lower than the leader are concentrated. This makes it suitable

for high conductivity samples as the concentration of the matrix ions are adjusted down while the trace

ions are concentrated. Biological samples are also ideal because sodium and chloride are typically in

high abundance and have a sufficiently high electrophoretic mobility to allow them function as leading

ions for a large number of target analytes. One of the consequences of the separation mechanism is that

the time of zone transitions depends on the concentrations of the species rather than on their mobilities,

and hence any variations in concentrations of ions with a mobility between the leader and target cause

the time of detection to change. Thus, ITP has predominantly been used coupled with another

separation like electrophoresis (ITP/ZE) to allow for analyte identification based on migration time.

This can be performed by coupling two separate microchannels such that zones from the ITP channel

are separated in a second electrophoresis channel, or in a single channel in a transient (tITP) manner.

This is where an initial ITP separation is induced to equalize the concentrations of all ions in the

sample prior to the ITP being dissipated transitioning to a normal zone electrophoresis separation.

Applications include concentrating small RNAs from cell lysate samples,21 coupled with GE for

analysis of DNA in PCR samples,22 and coupled with CE for analysis of proteins in infant milk

formula23 and urinary proteins in clinical samples.24

Because ITP/ZE is compatible with high salinity samples, a direct live cell assay from high

ionic strength (>140 mM NaCl) media was possible by ITP-ZE. In a microchip containing 5 ports for

loading of the different BGEs, the switch from ITP to ZE was done by introducing LE behind the

concentrated plug without additional sample pretreatment.25 The same principle was applied for DNA

genotyping of hepatitis B virus in serum samples after one PCR amplification round and 10 times

dilution of the product.26

For an analyte to reach the steady state and form a plateau in an ITP system, it has to exceed a

limiting concentration determined by its electrophoretic mobility and LE concentration according to

Kohlrausch regulating function. Trace analytes will pass the detection point as sharp peaks squeezed

between concentrated zones of more abundant analytes. This has recently been called peak-mode ITP.

The most significant application of this mode of ITP in recent years was demonstrated by the Santiago

group who concentrated and purified DNA. Proteins are removed through digestion with Proteinase K,

with the nucleic acids concentrated from the mixture and collected in the end reservoir for PCR. This

process is a quick and powerful alternative to solid-phase extraction – the only other DNA purification

method that has been routinely implemented in microchips. Subsequent to this work, the same group

has also demonstrated the ability to purify and concentrate RNA. Extraction of RNA with adequate

RNase control and RNA integrity was achieved from whole human blood infected with Pseudomonas

putida within 5 min.27 The TE chemistry was chosen to protect the RNA from exogenous and

endogenous RNase degradation.

Builiding on this further, Santiago’s group demonstrated the power of ITP for derivatisation

by forcing target nucleic acid and a fluorescent hybridization probe with complimentary sequence into

the same space in peak-mode ITP to achieve simultaneous purification, concentration and

hybridization. The most significant outcome is a significant increase in hybridization kinetics –

approximately 2-3 orders of magnitude such that hybridizations that took hours were completed in

seconds. A number of approaches were presented based upon this to improve the ability to detect

specific fragments of target DNA. The first was the use of molecular beacons which fluoresce only

after binding with a complimentary sequence but self-quench in free state (Figure 1).28 The second

approach was to use a hybridization probe and to remove the excess probe on photopatterned hydrogel

functionalized with complimentary DNA which allowed the use of higher probe concentrations (Figure

2).29 Later, a spacer ion in conjunction with a sieving matrix was used to separate the hybridized DNA

from the free-probe30. The spacer ion was chosen such that it had a mobility lower than the LE, probe,

target, and probe-target complexes to allow mixing and hybridization. When the zones entered the

sieving matrix, the mobility of the probe-target complex was reduced to below that of the spacer, thus

facilitating separation from the free-probe while still maintaining allowing the probe-target to separate

in an ITP zone to preserve sensitivity. This work is undoubtedly the most exiting in the field of

electrokinetic sample preparation as it provides a solid basis upon which it is entirely feasible to

developed sub-minute genetic diagnostics for quite complex analyses.

Electrokinetics with chemical selectivity

The approaches discussed above exploit only differences in electrophoretic mobility in order

to perform change in the sample in some way. Superimposable on these are a number of ways in which

to alter the mobility of the target species through chemical interactions. Historically the oldest is the

use of pH to alter ionization of weak acids, bases and ampholytes. Akin to isoelectric focusing (which

uses a shallow pH gradient to cause ampholytes to focus at discrete points) a ‘dynamic pH junction’ –

also called a moving neutralization boundary (MNB) – is a step pH gradient to concentrate all target

analytes at the boundary. To create the pH boundary, the sample should have a pH different from that

of the separation electrolyte so that the analytes of interest will slow down when reaching the BGE.

Dynamic pH junction is very useful for on-line sample pretreatment of weakly ionized analytes in

biological samples because it is tolerant of the salt concentration. Although the technique is often used

for the analysis of complex samples in CE, its uptake at the microchip format has been limited.31 We

expect more developments on this in the future as dynamic pH junction can benefit from the flexibility

in microchip design and automation.

The most widespread chemical interaction used in electrokinetic sample preparation is called

‘sweeping’. In sweeping, analytes are ‘swept’ to the sample/BGE interface by interacting with an

additive migrating through the sample zone. This is typically performed with micelles, but can be

performed with any compound that shows a strong affinity with the targets, as long as the affitinty

interaction results in a change in mobility in comparison with the free analyte. In microchips, 90, 170-,

and 1500-fold increase in the sensitivity for the fluorescent dyes sulforhodamine B, rhodamine B, and

cresyl fast violet was reported and because this technique is technically tolerant of salt, it is applicable

to biological samples but this has yet to be realised.32 MEKC/CE was reported for separation of model

tryptic digest.33

The most recent electrokinetic purification approach to emerge is the use of an immiscible

organic phase. This has been termed electromembrane extraction (EME) and has been demonstrated to

be a very simple and powerful approach to include additional selectivity. It resembles liquid-liquid

extraction but the applied electric field makes it much faster and more efficient. The organic phase is

selective for lipophilic, non-polar targets, which allows their extraction from the sample matrix. For

example, amitriptyline metabolism by rat liver microsomes was monitored on-line by extraction into 2-

nitrophenyl octyl ether (NPOE) supported by a 25 μm polypropylene membrane in a PMMA chip

coupled to electrospray ionization mass spectrometry (Figure 3).34 The applied voltage caused the

ionized non-polar amitriptyline to migrate to and through the membrane into the acceptor stream while

more hydrophilic solutes could not pass the organic barrier. Recent work by Kuban et al. has

demonstrated very rapid sampling times by directly sampling on the membrane with the tip of the

capillary for analysis of perchlorate in biological samples like serum, urine, and milk.35 Although this

method was reported for a conventional CE, its potential for use with microfluidic devices is very high.

Nano-/micro-channel interfaces

Unique properties at nano-/micro-channel interfaces have created an array of options based on

electrokinetic trapping. The mechanism is not fully understood but is expected to balance the

electrophoretic, hydrodynamic, and EOF forces acting on the analyte (Figure 4). Through the

combination of size exclusion and charge permselectivity, ions are selectively transported through the

nanopore creating a charge imbalance: a phenomena known as ion concentration polarization (ICP). In

order to preserve the electroneutrality on either side of the nanochannel, the transport of cations is

affected resulting in the anions and cations being depleted on the anodic side of the nanopores while

enriched on the cathodic side. Factors including the applied field strength, surface charge and charge

density, and fluid viscosity will affect the extent and rate of enrichment. The use of nanopores is of

great interest because of the ease with which it can be integrated into a microdevice and its immense

potential for sample preparation. For example, a concentration enhancement of more than 1,000,000 of

fluorescent dyes from water has been reported by ICP 7, 36.

There are a number of ways in which nanopores can be incorporated into a microfluidic

device. The first, and most obvious is through direct fabrication using e-beam lithography, providing a

great level of control of the size and shape of the nanochannels. Simultaneous concentration and

separation of two proteins was achieved in a microfluidic device with a nanochannel of varying width

by having low and high salt concentration at the nanochannels ends and creating a conductivity

gradient.42 Proteins were concentrated in different locations where their electrophoretic mobility was

balanced with the EOF reaching enhancements of 1000-fold within 17 min. The technique does not

require electric double layer overlap and hence can tolerate high ionic strength samples. Another

variation is depletion zone ITP which combines ITP with ion concentration polarization and the EOF in

the microchannel balances the depletion zone created at the interface with the nanochannels.43 Small

fluorescent dyes and labeled amino acids were enriched within 100 s and specific elution of analyte

zones was achieved using non-fluorescent spacers. Because this mechanism relies on the extent of

overlap of the double layer in the pores, this technique depends on the ionic strength and the size of the

nanopores. Widespread use of direct nanochannel fabrication is not common because of the expense of

the infrastructure required to pattern the nanochannels and the difficulty in bonding.

The second way in which nanopores have been integrated into microfluidic device is through

the incorporation of a photopolymerized hydrogel, allowing the use of lithographic principles to

accurately control the the position of the hydrogel. The chemistry can be used to define the physical

and chemical nature of the pores – the functional monomer(s) determine(s) the charge and surface

charge density while the pore size is controlled by the type and amount of cross-linker. For example, a

hydrophilic hydrogel with sulfonic acid groups (pKa <1) was used to enrich fluorescein and TRITC-

tagged albumin up to 1000 fold within 20 min from a sample matrix composed of 20 mM phosphate

buffer and 45 mM KCl37. While relatively easy to make, the pore size within the hydrogel is not

uniform with a smaller pore size in the center of the material than near the edge, which can lower their

ability to offer high enhancement factors. Also, shrinking and swelling in response to changes in

buffer ionic strength, temperature, and other environmental factors may disrupt the ICP and diminish

the achievable concentration enhancement factors as it is usually accompanied with pore size changes.

However this phenomena may also be exploited as demonstrated by Li et al., who demonstrated the

concentration and then elution of small molecules using a thermo-switchable hydrogel.38 The hydrogel

swells and becomes hydrophilic below ~ 32oC forming nanopores but shrinks and becomes

hydrophobic above this temperature allowing transport of small molecules like FITC and labeled

amino acids through the hydrogel. These were concentrated 17- to 22-fold in 50 μM sodium

tetraborate buffer within 3 min. Considering the dramatic deterioration of performance by increasing

ionic strength to just 10 mM and that physiological ionic strength is higher than 100 mM, it is clear that

significant work is required on this approach for it to be widely applicable to biological fluids.

The third approach, the integration of a nanoporous membrane, allows for the incorporation of

more defined nanopores, and has been realized by sandwiching a suitable membrane (such as a

nafion® membrane) between two microchips halves during bonding. This approach was used with a

track-etched polycarbonate membrane for the analysis of reduced glutathione directly from human

plasma, without any off-chip deproteinization. By allowing the glutathione to diffuse through the

membrane, it could then be analysed by CE with fluorescence detection. The same chip was used to

achieve 80-fold enhancement of DNA in less than 1 min by restricting DNA from passing through the

membrane and concentrating on one side of the membrane.40 In another approach, purification,

desalting, and concentration of DNA were simultaneously achieved in microchips using a capillary

with two notches in the wall covered with conductive Nafion® membranes permeable to small ions but

not DNA.41 The purified DNA was then released by switching off or reversing the electric field. A

recovery of 95% was obtained from crude DNA sample. However, at the high ionic strengths of most

biological samples, the membrane deforms and can rupture which limits the achievable enhancement

factors for biological samples.

The fourth alternative to create nanopores is through electric breakdown, forming

microfissures and cracks by applying an electric field higher than the dielectric breakdown of the

material. These microfissures and cracks were used to concentrate proteins by up to 1,000,000-fold7,

however, the lack of control over the resulting pore size limits the reproducibility of this approach.

Recently, this was overcome by monitoring the current during breakdown and down-regulating the

voltage when a specific current was reached. Setting a low threshold current produced smaller pores

while larger pores could be achieved with higher thresholds (Figure 5).39 The method was applied for

the direct determination of quinine from human whole blood without any sample preparation indicating

this technique is directly applicable to high salt biological fluids.

Conclusion

The increased interest in being able to perform laboratory quality measurements of biological samples

on-site for point-of-care personalized medicine has created a great need for efficient on-line sample

pretreatment of complex samples. There is currently no universally applicable approach that can be

used for all applications but there are many approaches that show great promise for specific

applications. High sensitivity, high throughput, and high selectivity are the key points to consider but

there are additional requirements of cost, simplicity and reliability. Research towards the development

of new simple, sample preparation methods that can be easily integrated into a microchip is expected to

grow exponentially, and because of the immense flexibility and simple hardware required

electrokinetic methods will become increasingly prominent in future devices.

Key Terms

Electroosmotic flow (EOF)

Liquid movement induced by voltage application across a capillary tube with charged internal surface.

Fused silica capillaries walls acquire a negative charge when filled with a solution with pH > 7. An

electric double layer forms where cations, positively charged, are attracted to the negatively charged

surface. When voltage is applied, cations moves toward the cathode and drag water molecules with

them creating cathodic or normal EOF. The EOF direction is toward the anode in case of positively

charged capillary surfaces. The EOF is characterized by flat front when compared to the dome-shaped

front of hydrodynamic flow as the dragging force originates closer to the capillary surface.

Background electrolyte (BGE)

The buffering solution used to fill the capillary/microchannel to provide background conductance

during electrophoretic separations

Kohlrausch regulating function

This function is an equation describing the relationship between the transference numbers (fraction of

current carried by one ionic species) and concentrations of faster moving and slower moving ions in a

stable moving boundary system.

Field Amplified Sample Injection (FASI)

When ions are injected electrokinetically from a low conductivity sample into higher conductivity

BGE, they experience a drop in the electric field and slow down and stack on the boundary between the

sample and BGE.

Field Amplified Sample Stacking (FASS)

Same as FASI except that the sample is hydrodynamically injected. Stacking does not occur till the

voltage is applied.

Ion concentration polarization (ICP)

A unique phenomenon associated with nanochannel connecting two microchannels due to imbalanced

ion transport under applied electric field. Under nearly overlapped electric double layer conditions,

negatively charged nanochannels favor the transport of cations and restrict anions resulting in depletion

zone of ions on the anodic side and enrichment zone on the cathodic side of the nanochannels.

Executive Summary

Biological samples often require extensive treatment which can be time consuming and

introduce a source of human errors.

Microfluidic approaches are attractive for the analysis of biological samples because of the

potential to conduct the complete analysis in an automated way on a single device.

Electrokinetic methods do not require pumps or moving parts, hence are compatible with on-

chip integration and automation. .

Isotachophoresis has the unique ability to cope with high salinity samples, with demonstrated

enhancement factors of up to a million-fold.

Methods based on ion concentration polarization hold more options but better understanding

is required to increase their reproducibility and stability and minimize variations due to the

sample matrix.

Bibliography

1. L. Llanes, A. Ferruelo, M. Lujan, C. Pascual, J. M. Garcia-Mediero and A. Berenguer, Prostate Cancer Prostatic Dis 8 (3), 248-252 (2005).

2. S. Potluri, H. O. Ventura, M. Mulumudi and M. R. Mehra, Cardiology in Review 12 (1), 21-25 (2004).

3. A. E. Herr, A. V. Hatch, D. J. Throckmorton, H. M. Tran, J. S. Brennan, W. V. Giannobile and A. K. Singh, Proceedings of the National Academy of Sciences 104 (13), 5268-5273 (2007).

4. C.-C. Lin, J.-H. Wang, H.-W. Wu and G.-B. Lee, Journal of the Association for Laboratory Automation 15 (3), 253-274 (2010).

5. B. Jung, R. Bharadwaj and J. G. Santiago, Analytical Chemistry 78 (7), 2319-2327 (2006).

6. Y.-C. Wang, A. L. Stevens and J. Han, Analytical Chemistry 77 (14), 4293-4299 (2005).

7. S. M. Kim, M. A. Burns and E. F. Hasselbrink, Analytical Chemistry 78 (14), 4779-4785 (2006).

8. P. Wagli, Y.-C. Chang, A. Homsy, L. Hvozdara, H. P. Herzig and N. F. de Rooij, Analytical Chemistry 85 (15), 7558-7565 (2013).

9. K. L. Helton, K. E. Nelson, E. Fu and P. Yager, Lab on a Chip 8 (11), 1847-1851 (2008).

10. E. X. Vrouwe, R. Luttge, I. Vermes and A. Van Den Berg, Clinical Chemistry 53 (1), 117-123 (2007).

11. M. Gong, K. R. Wehmeyer, P. A. Limbach, F. Arias and W. R. Heineman, Analytical Chemistry 78 (11), 3730-3737 (2006).

12. D. J. Weiss, K. Saunders and C. E. Lunte, Electrophoresis 22 (1), 59-65 (2001).

13. D. K. Kim and S. H. Kang, Journal of Chromatography A 1064 (1), 121-127 (2005).

14. M. J. A. Shiddiky and Y. B. Shim, Analytical Chemistry 79 (10), 3724-3733 (2007).

15. A. E. Herr, J. I. Molho, K. A. Drouvalakis, J. C. Mikkelsen, P. J. Utz, J. G. Santiago and T. W. Kenny, Analytical Chemistry 75 (5), 1180-1187 (2003).

16. J. Han and A. K. Singh, Journal of Chromatography A 1049 (1-2), 205-209 (2004).

17. S. S. Bahga, G. V. Kaigala, M. Bercovici and J. G. Santiago, Electrophoresis 32 (5), 563-572 (2011).

18. D. Bottenus, T. Z. Jubery, P. Dutta and C. F. Ivory, Electrophoresis 32 (5), 550-562 (2011).

19. D. Bottenus, T. Z. Jubery, Y. Ouyang, W. J. Dong, P. Dutta and C. F. Ivory, Lab on a Chip - Miniaturisation for Chemistry and Biology 11 (5), 890-898 (2011).

20. D. Bottenus, M. R. Hossan, Y. Ouyang, W. J. Dong, P. Dutta and C. F. Ivory, Lab on a Chip - Miniaturisation for Chemistry and Biology 11 (22), 3793-3801 (2011).

21. R. B. Schoch, M. Ronaghi and J. G. Santiago, Lab on a Chip - Miniaturisation for Chemistry and Biology 9 (15), 2145-2152 (2009).

22. D. Liu, Z. Ou, M. Xu and L. Wang, Journal of Chromatography A 1214 (1-2), 165-170 (2008).

23. R. Wu, Z. Wang, W. Zhao, W. S. B. Yeung and Y. S. Fung, Journal of Chromatography A 1304, 220-226 (2013).

24. R. Wu, W. S. B. Yeung and Y. S. Fung, Electrophoresis 32 (23), 3406-3414 (2011).

25. A. Wainright, S. J. Williams, G. Ciambrone, Q. Xue, J. Wei and D. Harris, Journal of Chromatography A 979 (1–2), 69-80 (2002).

26. D. Liu, M. Shi, H. Huang, Z. Long, X. Zhou, J. Qin and B. Lin, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 844 (1), 32-38 (2006).

27. A. Rogacs, Y. Qu and J. G. Santiago, Analytical Chemistry 84 (14), 5858-5863 (2012).

28. M. Bercovici, G. V. Kaigala, K. E. MacH, C. M. Han, J. C. Liao and J. G. Santiago, Analytical Chemistry 83 (11), 4110-4117 (2011).

29. G. Garcia-Schwarz and J. G. Santiago, Analytical Chemistry 84 (15), 6366-6369 (2012).

30. C. Eid, G. Garcia-Schwarz and J. G. Santiago, Analyst 138 (11), 3117-3120 (2013).

31. A. A. Kazarian, E. F. Hilder and M. C. Breadmore, Journal of Separation Science 34 (20), 2800-2821 (2011).

32. Y. Sera, N. Matsubara, K. Otsuka and S. Terabe, Electrophoresis 22 (16), 3509-3513 (2001).

33. W. H. Henley and J. M. Ramsey, Electrophoresis 33 (17), 2718-2724 (2012).

34. N. J. Petersen, S. T. Foss, H. Jensen, S. H. Hansen, C. Skonberg, D. Snakenborg, J. P. Kutter and S. Pedersen-Bjergaard, Analytical Chemistry 83 (1), 44-51 (2011).

35. P. Kubáň, I. K. Kiplagat and P. Boček, Electrophoresis 33 (17), 2695-2702 (2012).

36. Y. C. Wang, A. L. Stevens and J. Han, Analytical Chemistry 77 (14), 4293-4299 (2005).

37. H. Chun, T. D. Chung and J. M. Ramsey, Analytical Chemistry 82 (14), 6287-6292 (2010).

38. Z. Li, Q. He, D. Ma, H. Chen and S. A. Soper, Analytical Chemistry 82 (24), 10030-10036 (2010).

39. A. I. Shallan, A. J. Gaudry, R. M. Guijt and M. C. Breadmore, Chemical Communications 49 (27), 2816-2818 (2013).

40. Z. Long, D. Liu, N. Ye, J. Qin and B. Lin, Electrophoresis 27 (24), 4927-4934 (2006).

41. S.-R. Park and H. Swerdlow, Analytical Chemistry 75 (17), 4467-4474 (2003).

42. D. W. Inglis, E. M. Goldys and N. P. Calander, Angewandte Chemie 123 (33), 7688-7692 (2011).

43. J. Quist, K. G. H. Janssen, P. Vulto, T. Hankemeier and H. J. Van Der Linden, Analytical Chemistry 83 (20), 7910-7915 (2011).

Figure 1. (a) Schematic showing simultaneous isotachophoretic ex- traction, focusing, hybridization (with molecular beacons), and detec- tion of 16S rRNA bound to a molecular beacon. Hybridization of the molecular beacon to 16S rRNA causes a spatial separation of its fluorophore and quencher pair resulting in a strong and sequence- specific increase in fluorescent signal. (b) Raw experimental image showing fluorescence intensity of molecular beacons hybridized to synthetic oligonucleotides using ITP. (c) Detection of oligonucleotides having the same sequence as the target segment of 16S rRNA. Each curve presents the fluorescence intensity in time, as recorded by a point detector at a fixed location in the channel (curves are shifted in time for convenient visualization). 100 pM of molecular beacons and varying concentrations of targets were mixed in the trailing electrolyte reservoir. The total migration (and hybridization) time from the on-chip reservoir to the detector was less than a minute. Reprinted with permission from M. Bercovici, G. V. Kaigala, K. E. MacH, C. M. Han, J. C. Liao and J. G. Santiago, Analytical Chemistry 83 (11), 4110-4117 (2011). Copyright 2011 American Chemical Society.

Figure 2. Integration of on-chip ITP and affinity hydrogel enables sensitive NA detection. (A) Schematic of ITP-based hybridization enhancement. ITP enables rapid mixing and approximately 10 000-fold preconcentration of NAs and fluorescent reporters in a picoliter volume. Preconcentration drives forward the reaction between target and reporter molecules, dramatically decreasing hybridization time. (B) Experimental images demonstrating ITP hydrogel capture. The ITP-focused fluorescent oligo migrates through the hydrogel, which is functionalized with probes complementary to reporters. Thus, the capture gel continuously immobilizes unreacted reporter molecules. After the ITP zone sweeps by, we observe a weak fluorescent signal left behind in the gel, corresponding to captured unused probes. (C) Schematic of microRNA detection assay. ITP in a polyacrylamide gel (upstream of the photopatterned capture gel) preconcentrates and mixes target and reporter molecules, speeding up hybridization. The ITP zone then migrates into and through the capture gel region, which removes unhybridized reporters from the focused ITP zone. This allows minimal-background detection of reporters which have specifically hybridized to their complementary target microRNA. Reprinted with permission from G. Garcia-Schwarz and J. G. Santiago, Analytical Chemistry 84 (15), 6366-6369 (2012). Copyright 2012 American Chemical Society.

Figure 3. Schematic illustration of on-chip electro membrane system. Reprinted with permission fromN. J. Petersen, S. T. Foss, H. Jensen, S. H. Hansen, C. Skonberg, D. Snakenborg, J. P. Kutter and S. Pedersen-Bjergaard, Analytical Chemistry 83 (1), 44-51 (2011). Copyright 2011 American Chemical Society.

Figure 4. Mechanism of preconcentration in the nanofilter device (A) No concentration polarization is observed when a small electrical field (En) is applied across the nanofilter. (B) As the En increases, the transport of ions becomes diffusion-limited and generates the ion- depletion zone. However, the region maintains its electroneutrality. (C) Once a strong field (En) is applied, the nanochannel will develop an induced space charge layer, where electroneutrality is no longer maintained. (D) By applying an additional field (ET) along the microfluidic channel in the anodic side (from VS to VD), a nonlinear electrokinetic flow (called electroosmosis of the second kind) is induced, which results in fast accumulation of biomolecules in front of the induced space charge layer. Reprinted with permission from Y. C. Wang, A. L. Stevens and J. Han, Analytical Chemistry 77 (14), 4293-4299 (2005). Copyright 2005 American Chemical Society.

Figure 5. Screen shots showing the permeability of nanochannels created with decreasing current limits for red blood cells, labelled BSA (blue), CNF (red), R6G (green) and the inorganic ions, iron(III) and thiocyanate. Images on the left show blocked transport while those on the right show permeability. In each image, sample compartment is on the left and separation channel on the right.